<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">JCNR</journal-id><journal-title-group><journal-title>Journal of Clinical and Nursing Research</journal-title></journal-title-group><issn>2208-3685</issn><eissn>2208-3693</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/jcnr.v9i7.11460</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>TCT for Atypical Glandular Epithelium in 1 Case and Clinical Analysis</title><url>https://artdesignp.com/journal/JCNR/9/7/10.26689/jcnr.v9i7.11460</url><author>SongWenling,TianMiao</author><pub-date pub-type="publication-year"><year>2025</year></pub-date><volume>9</volume><issue>7</issue><history><date date-type="pub"><published-time>2025-08-04</published-time></date></history><abstract>Objective: Cervical adenocarcinoma (ECA) screening has low sensitivity and is prone to missed diagnoses. By analyzing a case of atypical glandular epithelium on TCT, this study aims to improve the clinical diagnosis and treatment of such diseases. Methods: The clinical examination findings, laboratory tests, and diagnostic process of a case with atypical glandular epithelium on TCT were analyzed. Results: The patient was diagnosed with cervical adenocarcinoma. Preoperative symptoms and imaging studies suggested the possibility of adenocarcinoma, and postoperative pathology confirmed the diagnosis of cervical adenocarcinoma (ECA). Conclusion: Through the analysis of this case, we aim to improve the clinical diagnosis and treatment of this condition.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Li J, Sun X, Zhao C, et al., 2020, Challenges to Cervical Adenocarcinoma Screening. Chinese Clinical Journal of Obstetrics and Gynecology, 21(2): 212–215. doi:10.13390/j.issn.1672-1861.2020.02.031</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Dong L, Qiao Y, 2016, Cervical Adenocarcinoma and HPV. Journal of Practical Obstetrics and Gynecology, 32(8): 561–562.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Cheng Y, Xie X, 2016, Screening for Cervical Adenocarcinoma. Journal of Practical Obstetrics and Gynecology, 32(8): 3. doi:CNKI:SUN:SFCZ.0.2016-08-003</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Simona S, Lien H, Soslow RA, 2019, Recent Advances in Invasive Adenocarcinoma of the Cervix. Virchows Archiv, 475(5): 537–549.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Zhong L, Zhou Q, Wang H, et al., 2021, Analysis of the Prognostic Correlation Between HPV Infection and Special Types of Cervical Adenocarcinoma. Journal of Chongqing Medical University, 46(6): 700–703. doi:10.13406/j.cnki.cyxb.002826</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Liu Y, Kong W, 2017, Progress in the Treatment of Cervical Adenocarcinoma. Chinese Journal of Reproductive Health, 28(1): 91–93.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Koh WJ, Abu-Rustum NR, Bean S, et al., 2019, Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 17(1): 64–84.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><p>Stolnicu S, Barsan I, Hoang L, et al., 2018, International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix. The American Journal of Surgical Pathology, 42(2): 214–226.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><p>Lu S, Shen D, 2021, Update and Interpretation of the 5th Edition of the WHO Classification of Tumors of the Female Genital Organs. Chinese Journal of Obstetrics and Gynecology, 56(8): 5. doi:10.3760/cma.j.cn112141-20210518-00273</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B10" content-type="article"><label>10</label><element-citation publication-type="journal"><p>Shi H, Lu B, Lu W, 2022, Pathologic Classification of Adenocarcinoma of the Uterine Cervix. Chinese Medical Journal, 102(26): 2045–2049. doi:10.3760/cma.j.cn112137-20211026-02361</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B11" content-type="article"><label>11</label><element-citation publication-type="journal"><p>Hohn AK, Brambs CE, Hiller GGR, et al., 2021, 2020 WHO Classification of Female Genital Tumors. Geburtshilfe und Frauenheilkunde, 81(10): 1145–1153.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B12" content-type="article"><label>12</label><element-citation publication-type="journal"><p>Roma AA, Vivar ADD, Park KJ, et al., 2015, Invasive Endocervical Adenocarcinoma: A New Pattern-Based Classification System With Important Clinical Significance. American Journal of Surgical Pathology, 39(5): 667–672. doi:10.1097/PAS.0000000000000402</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B13" content-type="article"><label>13</label><element-citation publication-type="journal"><p>Stolnicu S, Hoang L, Chiu D, et al., 2019, Clinical Outcomes of HPV-Associated and Unassociated Endocervical Adenocarcinomas Categorized by the International Endocervical Adenocarcinoma Criteria and Classification (IECC). The American Journal of Surgical Pathology, 43(4): 466–474. doi:10.1097/PAS.0000000000001224</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B14" content-type="article"><label>14</label><element-citation publication-type="journal"><p>Chen L, Hua Y, 2024, Progress of Clinicopathologic Research on Cervical Cancer. Progress in Clinical Medicine, 14(4): 640–647. doi:10.12677/acm.2024.1441071</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B15" content-type="article"><label>15</label><element-citation publication-type="journal"><p>Roma AA, Mistretta T, Vivar DDA, et al., 2016, New Pattern-Based Personalized Risk Stratification System for Endocervical Adenocarcinoma With Important Clinical Implications and Surgical Outcome. Gynecologic Oncology, 141(1): 36–42.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B16" content-type="article"><label>16</label><element-citation publication-type="journal"><p>Abu-Rustum N, Yashar CM, Arend R, et al., 2023, NCCN Guidelines Insights: Cervical Cancer, Version 1.2024. Journal of the National Comprehensive Cancer Network, 21(12): 1224–1233.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B17" content-type="article"><label>17</label><element-citation publication-type="journal"><p>Lei C, Yu L, Deng J, et al., 2018, Clinical Significance of Atypical Glandular Cells in Cervical Cytologic Screening. Chinese Journal of Histochemistry and Cytochemistry, 27(4): 350–353. doi:10.16705/j.cnki.1004-1850.2018.04.008</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B18" content-type="article"><label>18</label><element-citation publication-type="journal"><p>Ma X, Xiang Y, Liu C, et al., 2021, Chinese Expert Consensus on the Diagnosis and Management of Adenocarcinoma in Situ of the Uterine Cervix (2021 Edition). Chinese Journal of Practical Gynecology and Obstetrics, 37(12): 1209–1213. doi:10.19538/j.fk2021120110</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B19" content-type="article"><label>19</label><element-citation publication-type="journal"><p>Zhao S, Chen H, Zhao F, 2022, A Systematic Review of the Current Status of Global Precancerous Cervical Lesions and Cervical Cancer Treatment Guideline Development. Chinese Medical Journal, 102(22): 11. doi:10.3760/cma.j.cn112137-20211106-02466</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B20" content-type="article"><label>20</label><element-citation publication-type="journal"><p>Di J, Zhang X, Zhao G, et al., 2024, Interpretation of the Guidelines for Comprehensive Prevention and Control of Cervical Cancer (2nd Edition). Chinese Journal of Maternal and Child Health, 15(2): 1–5. doi:10.19757/j.cnki.issn1674-7763.2024.02.001</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
